Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $2.3 billion.

  • Dexcom's Non-Current Assets rose 565.71% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.1 billion, marking a year-over-year increase of 1230.96%. This contributed to the annual value of $2.3 billion for FY2025, which is 565.71% up from last year.
  • According to the latest figures from Q4 2025, Dexcom's Non-Current Assets is $2.3 billion, which was up 565.71% from $2.3 billion recorded in Q3 2025.
  • Dexcom's 5-year Non-Current Assets high stood at $2.3 billion for Q4 2025, and its period low was $944.7 million during Q1 2021.
  • In the last 5 years, Dexcom's Non-Current Assets had a median value of $1.8 billion in 2023 and averaged $1.7 billion.
  • In the last 5 years, Dexcom's Non-Current Assets surged by 11063.83% in 2021 and then skyrocketed by 565.71% in 2025.
  • Quarter analysis of 5 years shows Dexcom's Non-Current Assets stood at $1.2 billion in 2021, then surged by 37.95% to $1.7 billion in 2022, then rose by 6.72% to $1.8 billion in 2023, then increased by 18.74% to $2.2 billion in 2024, then grew by 5.66% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q4 2025, $2.3 billion for Q3 2025, and $2.3 billion during Q2 2025.